Exact Mass: 359.1416

Exact Mass Matches: 359.1416

Found 78 metabolites which its exact mass value is equals to given mass value 359.1416, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Capecitabine

pentyl N-{1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-methyloxolan-2-yl]-5-fluoro-2-oxo-1,2-dihydropyrimidin-4-yl}carbamate

C15H22FN3O6 (359.1493)


Capecitabine is an orally-administered chemotherapeutic agent used in the treatment of metastatic breast and colorectal cancers. Capecitabine is a prodrug, that is enzymatically converted to fluorouracil (antimetabolite) in the tumor, where it inhibits DNA synthesis and slows growth of tumor tissue. L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01B - Antimetabolites > L01BC - Pyrimidine analogues C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C272 - Antimetabolite CONFIDENCE standard compound; EAWAG_UCHEM_ID 2845 D009676 - Noxae > D000963 - Antimetabolites D000970 - Antineoplastic Agents Capecitabine is an oral proagent that is converted to its active metabolite, 5-FU, by thymidine phosphorylase.

   

Clethodim

Clethodim

C17H26ClNO3S (359.1322)


D010575 - Pesticides > D006540 - Herbicides D016573 - Agrochemicals

   

N-[2-hydroxy-2-(4-hydroxy-3-methoxyphenyl)ethyl]-3-(4-hydroxy-3-methoxyphenyl)prop-2-enimidic acid

N-[2-hydroxy-2-(4-hydroxy-3-methoxyphenyl)ethyl]-3-(4-hydroxy-3-methoxyphenyl)prop-2-enimidic acid

C19H21NO6 (359.1369)


   

Chlorambucil-tertiary butyl ester

tert-butyl 4-{4-[bis(2-chloroethyl)amino]phenyl}butanoate

C18H27Cl2NO2 (359.1419)


D000970 - Antineoplastic Agents > D018906 - Antineoplastic Agents, Alkylating > D009588 - Nitrogen Mustard Compounds

   

Clethodim

2-((1E)-N-(((2E)-3-Chloro-2-propen-1-yl)oxy)propanimidoyl)-5-(2-(ethylsulfanyl)propyl)-3-hydroxy-2-cyclohexen-1-one

C17H26ClNO3S (359.1322)


   

Oxodipine

3-Ethyl 5-methyl 4-(2H-1,3-benzodioxol-4-yl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylic acid

C19H21NO6 (359.1369)


   

Lutessine

Ungiminorine 1-acetate

C19H21NO6 (359.1369)


   
   
   

(+)-10,11-dioxoepierythratidine

(+)-10,11-dioxoepierythratidine

C19H21NO6 (359.1369)


   

N-[2-(3,4-dihydroxyphenyl)-2-hydroxyethyl]-3-(3,4-dimethoxyphenyl)prop-2-enamide

N-[2-(3,4-dihydroxyphenyl)-2-hydroxyethyl]-3-(3,4-dimethoxyphenyl)prop-2-enamide

C19H21NO6 (359.1369)


   

3-O-acetylungiminorine|3-O-Acetylungminorine|ungiminorine acetate

3-O-acetylungiminorine|3-O-Acetylungminorine|ungiminorine acetate

C19H21NO6 (359.1369)


   

4,6,7-Trimethoxy-5-(2-hydroperoxy-3-methyl-3-butenyl)furo[2,3-b]quinoline

4,6,7-Trimethoxy-5-(2-hydroperoxy-3-methyl-3-butenyl)furo[2,3-b]quinoline

C19H21NO6 (359.1369)


   

(E)-1,1-dimethyl-3-(4,6,7-trimethoxyfuro[2,3-b]quinolin-5-yl)-2-propenyl hydroperoxide

(E)-1,1-dimethyl-3-(4,6,7-trimethoxyfuro[2,3-b]quinolin-5-yl)-2-propenyl hydroperoxide

C19H21NO6 (359.1369)


   

1-hydroxy-10-oxo-sinomenone

1-hydroxy-10-oxo-sinomenone

C19H21NO6 (359.1369)


   

2-methoxycassiarin B-3-one|cassiarin H

2-methoxycassiarin B-3-one|cassiarin H

C19H21NO6 (359.1369)


   

(+)-3alpha-methoxy-6beta-acetylbulbispermine

(+)-3alpha-methoxy-6beta-acetylbulbispermine

C19H21NO6 (359.1369)


   
   

Turbomycin A

Turbomycin A

C25H17N3 (359.1422)


   
   
   
   
   
   

Capecitabine

Capecitabine

C15H22FN3O6 (359.1493)


L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01B - Antimetabolites > L01BC - Pyrimidine analogues C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C272 - Antimetabolite D009676 - Noxae > D000963 - Antimetabolites D000970 - Antineoplastic Agents CONFIDENCE standard compound; INTERNAL_ID 2353 INTERNAL_ID 2353; CONFIDENCE standard compound CONFIDENCE standard compound; INTERNAL_ID 2140 CONFIDENCE standard compound; INTERNAL_ID 8343 CONFIDENCE standard compound; INTERNAL_ID 4129 Capecitabine is an oral proagent that is converted to its active metabolite, 5-FU, by thymidine phosphorylase.

   

Capecitabine (Xeloda)

Capecitabine (Xeloda)

C15H22FN3O6 (359.1493)


   
   

[1-(4-methoxyanilino)-1-oxopropan-2-yl] 6-oxo-1-propylpyridazine-3-carboxylate

[1-(4-methoxyanilino)-1-oxopropan-2-yl] 6-oxo-1-propylpyridazine-3-carboxylate

C18H21N3O5 (359.1481)


http://casmi-contest.org/challenges-cat1-2.shtml; CASMI2012 LC Challenge 16

   

Scillitazettine

Scillitazettine

C19H21NO6 (359.1369)


   
   
   

(S)-1,2,3,4-tetrahydro-1-phenylisoquinoline D-(-)-tartrate

(S)-1,2,3,4-tetrahydro-1-phenylisoquinoline D-(-)-tartrate

C19H21NO6 (359.1369)


   

Fmoc-L-threonine monohydrate

Fmoc-L-threonine monohydrate

C19H21NO6 (359.1369)


   

5-Deoxy-5-fluoro-N-[(2-methylbutoxy)carbonyl]cytidine

5-Deoxy-5-fluoro-N-[(2-methylbutoxy)carbonyl]cytidine

C15H22FN3O6 (359.1493)


   

DIETHYL 1-BENZYL-3,4-ETHYLENEDIOXYPYRRO&

DIETHYL 1-BENZYL-3,4-ETHYLENEDIOXYPYRRO&

C19H21NO6 (359.1369)


   

TRANS-1-(TERT-BUTOXYCARBONYL)-4-(3-(TRIFLUOROMETHYL)PHENYL)PYRROLIDINE-3-CARBOXYLIC ACID

TRANS-1-(TERT-BUTOXYCARBONYL)-4-(3-(TRIFLUOROMETHYL)PHENYL)PYRROLIDINE-3-CARBOXYLIC ACID

C17H20F3NO4 (359.1344)


   

(4-(N-(2-((TERT-BUTYLDIMETHYLSILYL)OXY)ETHYL)SULFAMOYL)PHENYL)BORONIC ACID

(4-(N-(2-((TERT-BUTYLDIMETHYLSILYL)OXY)ETHYL)SULFAMOYL)PHENYL)BORONIC ACID

C14H26BNO5SSi (359.1394)


   

(5R)-5-[(1S)-1,2-Dihydroxyethyl]-3,4-dihydroxy-2(5H)-furanone - 1 ,1-diphenylmethanamine (1:1) (non-preferred name)

(5R)-5-[(1S)-1,2-Dihydroxyethyl]-3,4-dihydroxy-2(5H)-furanone - 1 ,1-diphenylmethanamine (1:1) (non-preferred name)

C19H21NO6 (359.1369)


   

2,6-difluoro-N-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]benzamide

2,6-difluoro-N-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]benzamide

C19H20BF2NO3 (359.1504)


   

Oxodipine

Oxodipine

C19H21NO6 (359.1369)


C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C333 - Calcium Channel Blocker D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators C93038 - Cation Channel Blocker

   

5-Deoxy-5-fluoro-N4-(isopentyloxycarbonyl)cytidine

5-Deoxy-5-fluoro-N4-(isopentyloxycarbonyl)cytidine

C15H22FN3O6 (359.1493)


5′-Deoxy-5-fluoro-N4-(isopentyloxycarbonyl)cytidine is an impurity in the synthesis of Capecitabine (HY-B0016)[1].

   

methyl 2-[5-[(2-methylpropan-2-yl)oxycarbonylamino]-6-oxo-2-phenylpyrimidin-1-yl]acetate

methyl 2-[5-[(2-methylpropan-2-yl)oxycarbonylamino]-6-oxo-2-phenylpyrimidin-1-yl]acetate

C18H21N3O5 (359.1481)


   

(3S,4R)-1-(TERT-BUTOXYCARBONYL)-4-(4-(TRIFLUOROMETHYL)PHENYL)PYRROLIDINE-3-CARBOXYLIC ACID

(3S,4R)-1-(TERT-BUTOXYCARBONYL)-4-(4-(TRIFLUOROMETHYL)PHENYL)PYRROLIDINE-3-CARBOXYLIC ACID

C17H20F3NO4 (359.1344)


   

Isopropyl 2-[4-(3-chlorophenyl)piperazino]nicotinate

Isopropyl 2-[4-(3-chlorophenyl)piperazino]nicotinate

C19H22ClN3O2 (359.14)


   

N-(5-methyl-1,3,4-oxadiazol-2-yl)-3-(2-methylphenyl)-1-phenylpyrazole-4-carboxamide

N-(5-methyl-1,3,4-oxadiazol-2-yl)-3-(2-methylphenyl)-1-phenylpyrazole-4-carboxamide

C20H17N5O2 (359.1382)


   

gibberellin A25(2-)

gibberellin A25(2-)

C20H23O6-3 (359.1495)


   

7-Deoxyloganate

7-Deoxyloganate

C16H23O9- (359.1342)


A monocarboxylic acid anion that is the conjugate base of 7-deoxyloganic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

7-Epi-deoxyloganate

7-Epi-deoxyloganate

C16H23O9- (359.1342)


   

N-(4-acetamidophenyl)-2-[(5-cyclopropyl-4-ethyl-1,2,4-triazol-3-yl)thio]acetamide

N-(4-acetamidophenyl)-2-[(5-cyclopropyl-4-ethyl-1,2,4-triazol-3-yl)thio]acetamide

C17H21N5O2S (359.1416)


   
   

5-[1-[(3,5-Dimethoxyphenyl)methylamino]ethylidene]-1-prop-2-enyl-1,3-diazinane-2,4,6-trione

5-[1-[(3,5-Dimethoxyphenyl)methylamino]ethylidene]-1-prop-2-enyl-1,3-diazinane-2,4,6-trione

C18H21N3O5 (359.1481)


   

N-[2-[(2-methylphenyl)methylthio]ethyl]-3-[(4-methylphenyl)thio]propanamide

N-[2-[(2-methylphenyl)methylthio]ethyl]-3-[(4-methylphenyl)thio]propanamide

C20H25NOS2 (359.1377)


   

1-(4-Chlorophenyl)-3-[[1-(4-methoxyphenyl)-3-pyrrolidinyl]methyl]urea

1-(4-Chlorophenyl)-3-[[1-(4-methoxyphenyl)-3-pyrrolidinyl]methyl]urea

C19H22ClN3O2 (359.14)


   

N-[2-(4-Methoxy-phenyl)-6-methyl-2H-benzotriazol-5-yl]-nicotinamide

N-[2-(4-Methoxy-phenyl)-6-methyl-2H-benzotriazol-5-yl]-nicotinamide

C20H17N5O2 (359.1382)


   

[4-(5-Chloro-2-methylphenyl)-1-piperazinyl]-(2-ethoxy-3-pyridinyl)methanone

[4-(5-Chloro-2-methylphenyl)-1-piperazinyl]-(2-ethoxy-3-pyridinyl)methanone

C19H22ClN3O2 (359.14)


   

N-[2-(tert-butylamino)-2-oxo-1-pyridin-4-ylethyl]-N-cyclopropyl-4-thiadiazolecarboxamide

N-[2-(tert-butylamino)-2-oxo-1-pyridin-4-ylethyl]-N-cyclopropyl-4-thiadiazolecarboxamide

C17H21N5O2S (359.1416)


   
   
   
   
   
   

AVN-492

AVN-492

C17H21N5O2S (359.1416)


AVN-492 is a very specific and highly-selective antagonist with picomolar affinity to 5-HT6R (Ki=91 pM).

   

(1s,16r,17s,18s,19s)-16-hydroxy-17-methoxy-5,7-dioxa-12-azapentacyclo[10.6.1.0²,¹⁰.0⁴,⁸.0¹⁵,¹⁹]nonadeca-2,4(8),9,14-tetraen-18-yl acetate

(1s,16r,17s,18s,19s)-16-hydroxy-17-methoxy-5,7-dioxa-12-azapentacyclo[10.6.1.0²,¹⁰.0⁴,⁸.0¹⁵,¹⁹]nonadeca-2,4(8),9,14-tetraen-18-yl acetate

C19H21NO6 (359.1369)


   

3-[(3s,6s,11ar)-1,4-dihydroxy-3-[2-(methylsulfanyl)ethyl]-7-oxo-1h,2h,3h,6h,9h,10h,11h,11ah-pyrrolo[1,2-a][1,4,7]triazonin-6-yl]propanoic acid

3-[(3s,6s,11ar)-1,4-dihydroxy-3-[2-(methylsulfanyl)ethyl]-7-oxo-1h,2h,3h,6h,9h,10h,11h,11ah-pyrrolo[1,2-a][1,4,7]triazonin-6-yl]propanoic acid

C15H25N3O5S (359.1515)


   

(2e)-n-[(2r)-2-hydroxy-2-(4-hydroxy-3-methoxyphenyl)ethyl]-3-(4-hydroxy-3-methoxyphenyl)prop-2-enimidic acid

(2e)-n-[(2r)-2-hydroxy-2-(4-hydroxy-3-methoxyphenyl)ethyl]-3-(4-hydroxy-3-methoxyphenyl)prop-2-enimidic acid

C19H21NO6 (359.1369)


   

(1r,9r,10s)-3,6-dihydroxy-4,12-dimethoxy-17-methyl-17-azatetracyclo[7.5.3.0¹,¹⁰.0²,⁷]heptadeca-2,4,6,11-tetraene-8,13-dione

(1r,9r,10s)-3,6-dihydroxy-4,12-dimethoxy-17-methyl-17-azatetracyclo[7.5.3.0¹,¹⁰.0²,⁷]heptadeca-2,4,6,11-tetraene-8,13-dione

C19H21NO6 (359.1369)


   

(2r)-3-methyl-1-{4,6,7-trimethoxyfuro[2,3-b]quinolin-5-yl}but-3-ene-2-peroxol

(2r)-3-methyl-1-{4,6,7-trimethoxyfuro[2,3-b]quinolin-5-yl}but-3-ene-2-peroxol

C19H21NO6 (359.1369)


   

(2e)-n-[(2s)-2-(3,4-dihydroxyphenyl)-2-hydroxyethyl]-3-(3,4-dimethoxyphenyl)prop-2-enimidic acid

(2e)-n-[(2s)-2-(3,4-dihydroxyphenyl)-2-hydroxyethyl]-3-(3,4-dimethoxyphenyl)prop-2-enimidic acid

C19H21NO6 (359.1369)


   

(1r,11s,13s,15r,18s)-18-hydroxy-15-methoxy-5,7-dioxa-12-azapentacyclo[10.5.2.0¹,¹³.0²,¹⁰.0⁴,⁸]nonadeca-2,4(8),9,16-tetraen-11-yl acetate

(1r,11s,13s,15r,18s)-18-hydroxy-15-methoxy-5,7-dioxa-12-azapentacyclo[10.5.2.0¹,¹³.0²,¹⁰.0⁴,⁸]nonadeca-2,4(8),9,16-tetraen-11-yl acetate

C19H21NO6 (359.1369)


   

n-[2-(3,4-dihydroxyphenyl)-2-hydroxyethyl]-3-(3,4-dimethoxyphenyl)prop-2-enimidic acid

n-[2-(3,4-dihydroxyphenyl)-2-hydroxyethyl]-3-(3,4-dimethoxyphenyl)prop-2-enimidic acid

C19H21NO6 (359.1369)


   

(9bs,11r,12r)-12-hydroxy-7,8,11-trimethoxy-1h,2h,10h,11h,12h-indolo[7a,1-a]isoquinoline-4,5-dione

(9bs,11r,12r)-12-hydroxy-7,8,11-trimethoxy-1h,2h,10h,11h,12h-indolo[7a,1-a]isoquinoline-4,5-dione

C19H21NO6 (359.1369)


   

17-hydroxy-14-methoxy-5,7-dioxa-12-azapentacyclo[10.6.1.0²,¹⁰.0⁴,⁸.0¹⁵,¹⁹]nonadeca-2,4(8),9,15-tetraen-18-yl acetate

17-hydroxy-14-methoxy-5,7-dioxa-12-azapentacyclo[10.6.1.0²,¹⁰.0⁴,⁸.0¹⁵,¹⁹]nonadeca-2,4(8),9,15-tetraen-18-yl acetate

C19H21NO6 (359.1369)


   

3-[bis(1h-indol-3-yl)methylidene]indole

3-[bis(1h-indol-3-yl)methylidene]indole

C25H17N3 (359.1422)


   

2-methyl-4-{4,6,7-trimethoxyfuro[2,3-b]quinolin-5-yl}but-3-ene-2-peroxol

2-methyl-4-{4,6,7-trimethoxyfuro[2,3-b]quinolin-5-yl}but-3-ene-2-peroxol

C19H21NO6 (359.1369)


   

methyl 4-[(3s)-3-methoxy-3,7-dimethyl-4,11-dioxo-2-oxa-6-azatricyclo[7.3.1.0⁵,¹³]trideca-1(12),5(13),7,9-tetraen-6-yl]butanoate

methyl 4-[(3s)-3-methoxy-3,7-dimethyl-4,11-dioxo-2-oxa-6-azatricyclo[7.3.1.0⁵,¹³]trideca-1(12),5(13),7,9-tetraen-6-yl]butanoate

C19H21NO6 (359.1369)


   

12-hydroxy-7,8,11-trimethoxy-1h,2h,10h,11h,12h-indolo[7a,1-a]isoquinoline-4,5-dione

12-hydroxy-7,8,11-trimethoxy-1h,2h,10h,11h,12h-indolo[7a,1-a]isoquinoline-4,5-dione

C19H21NO6 (359.1369)


   

(3e)-2-methyl-4-{4,6,7-trimethoxyfuro[2,3-b]quinolin-5-yl}but-3-ene-2-peroxol

(3e)-2-methyl-4-{4,6,7-trimethoxyfuro[2,3-b]quinolin-5-yl}but-3-ene-2-peroxol

C19H21NO6 (359.1369)


   

18-hydroxy-15-methoxy-5,7-dioxa-12-azapentacyclo[10.5.2.0¹,¹³.0²,¹⁰.0⁴,⁸]nonadeca-2,4(8),9,16-tetraen-11-yl acetate

18-hydroxy-15-methoxy-5,7-dioxa-12-azapentacyclo[10.5.2.0¹,¹³.0²,¹⁰.0⁴,⁸]nonadeca-2,4(8),9,16-tetraen-11-yl acetate

C19H21NO6 (359.1369)